The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.
Sign up for our newsletter to get the latest info on HIV and AIDS:
In the U.S. nearly 20% of new HIV infections are among cisgender women (cis women) with higher rates among women of color. Yet rates of PrEP uptake among women have … Read More
The small group of young men who took part in a recent PrEP study by a group of California researchers liked being able to access PrEP services and care from … Read More
Daily use of PrEP reduces the risk of HIV infection by up to 99%. Yet there are a few factors that may keep people from seeing daily PrEP as an … Read More
Jared Hemming, site director of Strut, the San Francisco AIDS Foundation’s health and wellness center in the Castro, describes services at Strut this way: “Folks can come in and find … Read More
In San Francisco, the sixth case of PrEP failure in a patient with high adherence was reported at IDWeek 2018 by Stephanie Cohen, MD, medical director of San Francisco City … Read More
Using PrEP for HIV prevention does not lower levels of feminizing hormones, and hormones only slightly reduce tenofovir levels, according to research presented at the International AIDS Conference in Amsterdam. These … Read More
See more articles on the BETA Blog...